Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xavier Anglaret

Showing results (61-70 of 161) with videos related to

Pageof 17
Sort By:
AIDS Research and Human Retroviruses|February 1, 2007
Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'IvoireChristine Danel, Raoul Moh, Gilles Peytavin, et al.
HIV Clinical Trials|October 29, 2014
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trialsEric Ross, Frank Tanser, Pamela Pei, et al.
HIV Medicine|January 13, 2022
Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adultsRoseline Affi, Delphine Gabillard, Gérard Menan Kouame, et al.
AIDS (London, England)|April 26, 2007
HIV drug resistance surveillance for prioritizing treatment in resource-limited settingsRochelle P Walensky, Milton C Weinstein, Yazdan Yazdanpanah, et al.
Lancet (London, England)|February 24, 2015
Favipiravir for children with EbolaNaïm Bouazza, Jean-Marc Treluyer, Frantz Foissac, et al.
Antiviral Therapy|November 3, 2010
Occult HBV infection in untreated HIV-infected adults in Côte d'IvoireThérèse N'Dri-Yoman, Xavier Anglaret, Eugène Messou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2009
Comparison of early CD4 T-cell count in HIV-1 seroconverters in Côte d'Ivoire and France: the ANRS PRIMO-CI and SEROCO cohortsCharlotte Lewden, Rodolphe Thiébaut, Faroudy Boufassa, et al.
AIDS (London, England)|April 23, 2008
Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinantsSiaka Toure, Bertin Kouadio, Catherine Seyler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 19, 2010
Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'IvoireDidier K Ekouevi, Patrick A Coffie, Eric Ouattara, et al.
Journal of Gastroenterology and Hepatology|August 28, 2015
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan AfricaAnders Boyd, Sarah Maylin, Raoul Moh, et al.
Pageof 17

Showing results (61-70 of 161) with videos related to

Sort By:
Pageof 17
AIDS Research and Human Retroviruses|February 1, 2007
Lack of indinavir-associated nephrological complications in HIV-infected adults (predominantly women) with high indinavir plasma concentration in Abidjan, Côte d'IvoireChristine Danel, Raoul Moh, Gilles Peytavin, et al.
HIV Clinical Trials|October 29, 2014
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trialsEric Ross, Frank Tanser, Pamela Pei, et al.
HIV Medicine|January 13, 2022
Plasma sVCAM-1, antiretroviral therapy and mortality in HIV-1-infected West African adultsRoseline Affi, Delphine Gabillard, Gérard Menan Kouame, et al.
AIDS (London, England)|April 26, 2007
HIV drug resistance surveillance for prioritizing treatment in resource-limited settingsRochelle P Walensky, Milton C Weinstein, Yazdan Yazdanpanah, et al.
Lancet (London, England)|February 24, 2015
Favipiravir for children with EbolaNaïm Bouazza, Jean-Marc Treluyer, Frantz Foissac, et al.
Antiviral Therapy|November 3, 2010
Occult HBV infection in untreated HIV-infected adults in Côte d'IvoireThérèse N'Dri-Yoman, Xavier Anglaret, Eugène Messou, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 12, 2009
Comparison of early CD4 T-cell count in HIV-1 seroconverters in Côte d'Ivoire and France: the ANRS PRIMO-CI and SEROCO cohortsCharlotte Lewden, Rodolphe Thiébaut, Faroudy Boufassa, et al.
AIDS (London, England)|April 23, 2008
Rapid scaling-up of antiretroviral therapy in 10,000 adults in Côte d'Ivoire: 2-year outcomes and determinantsSiaka Toure, Bertin Kouadio, Catherine Seyler, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 19, 2010
Pregnancy outcomes in women exposed to efavirenz and nevirapine: an appraisal of the IeDEA West Africa and ANRS Databases, Abidjan, Côte d'IvoireDidier K Ekouevi, Patrick A Coffie, Eric Ouattara, et al.
Journal of Gastroenterology and Hepatology|August 28, 2015
Hepatitis B surface antigen quantification as a predictor of seroclearance during treatment in HIV-hepatitis B virus coinfected patients from Sub-Saharan AfricaAnders Boyd, Sarah Maylin, Raoul Moh, et al.
Pageof 17